LeMaitre Vascular ROE 2012-2025 | LMAT
Current and historical return on equity (ROE) values for LeMaitre Vascular (LMAT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| LeMaitre Vascular ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $0.05B | $0.38B | 14.86% |
| 2025-06-30 | $0.05B | $0.36B | 13.63% |
| 2025-03-31 | $0.05B | $0.35B | 13.47% |
| 2024-12-31 | $0.04B | $0.34B | 13.57% |
| 2024-09-30 | $0.04B | $0.33B | 13.04% |
| 2024-06-30 | $0.04B | $0.32B | 12.50% |
| 2024-03-31 | $0.03B | $0.31B | 11.53% |
| 2023-12-31 | $0.03B | $0.30B | 10.48% |
| 2023-09-30 | $0.03B | $0.29B | 10.04% |
| 2023-06-30 | $0.03B | $0.28B | 9.20% |
| 2023-03-31 | $0.02B | $0.27B | 7.92% |
| 2022-12-31 | $0.02B | $0.27B | 8.04% |
| 2022-09-30 | $0.02B | $0.26B | 8.15% |
| 2022-06-30 | $0.02B | $0.26B | 9.03% |
| 2022-03-31 | $0.03B | $0.26B | 11.40% |
| 2021-12-31 | $0.03B | $0.25B | 12.46% |
| 2021-09-30 | $0.03B | $0.25B | 14.25% |
| 2021-06-30 | $0.03B | $0.19B | 16.62% |
| 2021-03-31 | $0.03B | $0.18B | 15.04% |
| 2020-12-31 | $0.02B | $0.17B | 13.84% |
| 2020-09-30 | $0.02B | $0.16B | 13.09% |
| 2020-06-30 | $0.02B | $0.15B | 11.49% |
| 2020-03-31 | $0.02B | $0.15B | 12.48% |
| 2019-12-31 | $0.02B | $0.15B | 13.55% |
| 2019-09-30 | $0.02B | $0.14B | 14.73% |
| 2019-06-30 | $0.02B | $0.14B | 14.45% |
| 2019-03-31 | $0.02B | $0.13B | 18.07% |
| 2018-12-31 | $0.02B | $0.13B | 18.81% |
| 2018-09-30 | $0.02B | $0.13B | 17.91% |
| 2018-06-30 | $0.02B | $0.12B | 19.56% |
| 2018-03-31 | $0.02B | $0.11B | 16.86% |
| 2017-12-31 | $0.02B | $0.11B | 16.75% |
| 2017-09-30 | $0.02B | $0.11B | 16.67% |
| 2017-06-30 | $0.01B | $0.10B | 15.34% |
| 2017-03-31 | $0.01B | $0.09B | 13.71% |
| 2016-12-31 | $0.01B | $0.09B | 12.98% |
| 2016-09-30 | $0.01B | $0.09B | 13.37% |
| 2016-06-30 | $0.01B | $0.08B | 12.66% |
| 2016-03-31 | $0.01B | $0.08B | 11.88% |
| 2015-12-31 | $0.01B | $0.08B | 11.03% |
| 2015-09-30 | $0.01B | $0.07B | 10.00% |
| 2015-06-30 | $0.01B | $0.07B | 8.79% |
| 2015-03-31 | $0.01B | $0.07B | 7.38% |
| 2014-12-31 | $0.00B | $0.07B | 6.18% |
| 2014-09-30 | $0.00B | $0.07B | 4.84% |
| 2014-06-30 | $0.00B | $0.07B | 5.08% |
| 2014-03-31 | $0.00B | $0.06B | 5.41% |
| 2013-12-31 | $0.00B | $0.06B | 7.31% |
| 2013-09-30 | $0.00B | $0.06B | 7.44% |
| 2013-06-30 | $0.00B | $0.05B | 7.55% |
| 2013-03-31 | $0.00B | $0.05B | 7.62% |
| 2012-12-31 | $0.00B | $0.05B | 5.74% |
| 2012-09-30 | $0.00B | $0.05B | 3.85% |
| 2012-06-30 | $0.00B | $0.05B | 3.83% |
| 2012-03-31 | $0.00B | $0.05B | 3.81% |
| 2011-12-31 | $0.00B | $0.05B | 3.81% |
| 2011-09-30 | $0.00B | $0.05B | 7.62% |
| 2011-06-30 | $0.01B | $0.05B | 9.62% |
| 2011-03-31 | $0.01B | $0.05B | 11.76% |
| 2010-12-31 | $0.01B | $0.05B | 13.93% |
| 2010-09-30 | $0.01B | $0.05B | 12.18% |
| 2010-06-30 | $0.01B | $0.05B | 10.36% |
| 2010-03-31 | $0.00B | $0.05B | 8.42% |
| 2009-12-31 | $0.00B | $0.05B | 2.16% |
| 2009-09-30 | $0.00B | $0.05B | 0.00% |
| 2009-06-30 | $0.00B | $0.05B | -2.21% |
| 2009-03-31 | $0.00B | $0.04B | -6.63% |
| 2008-12-31 | $0.00B | $0.05B | -8.70% |
| 2008-09-30 | $-0.01B | $0.05B | -10.70% |
| 2008-06-30 | $-0.01B | $0.05B | -12.50% |
| 2008-03-31 | $-0.01B | $0.05B | -10.20% |
| 2007-12-31 | $0.00B | $0.05B | -6.03% |
| 2007-06-30 | $0.00B | $0.05B | -5.30% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.983B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $192.719B | 21.52 |
| EssilorLuxottica (ESLOY) | France | $140.970B | 0.00 |
| Stryker (SYK) | United States | $137.019B | 26.29 |
| Medtronic (MDT) | Ireland | $131.919B | 18.28 |
| Boston Scientific (BSX) | United States | $113.066B | 25.01 |
| Medline (MDLN) | United States | $62.139B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.969B | 0.00 |
| ResMed (RMD) | United States | $39.571B | 26.42 |
| GE HealthCare Technologies (GEHC) | United States | $36.756B | 17.61 |
| Agilent Technologies (A) | United States | $36.736B | 23.22 |
| Koninklijke Philips (PHG) | Netherlands | $28.368B | 18.53 |
| Terumo (TRUMY) | Japan | $19.441B | 21.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Insulet (PODD) | United States | $17.019B | 52.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.739B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.133B | 29.24 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.785B | 24.25 |
| Lantheus Holdings (LNTH) | United States | $4.303B | 13.11 |
| BillionToOne (BLLN) | United States | $4.147B | 0.00 |
| ICU Medical (ICUI) | United States | $3.806B | 24.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.139B | 14.81 |
| Haemonetics (HAE) | United States | $2.758B | 12.06 |
| Neogen (NEOG) | United States | $2.349B | 51.43 |
| Phibro Animal Health (PAHC) | United States | $2.151B | 18.95 |
| Perrigo (PRGO) | Ireland | $2.015B | 5.05 |
| QuidelOrtho (QDEL) | United States | $1.977B | 12.71 |
| AtriCure (ATRC) | United States | $1.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.622B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.475B | 64.64 |
| AdaptHealth (AHCO) | United States | $1.442B | 20.88 |
| Capricor Therapeutics (CAPR) | United States | $1.130B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.080B | 320.43 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.021B | 0.00 |
| InMode (INMD) | Israel | $0.953B | 10.77 |
| Tilray Brands (TLRY) | Canada | $0.883B | 0.00 |
| Valneva SE (VALN) | France | $0.817B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.803B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.587B | 15.91 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.427B | 72.60 |
| Cerus (CERS) | United States | $0.423B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.405B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.328B | 26.18 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.292B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.222B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.197B | 17.71 |
| Aurora Cannabis (ACB) | Canada | $0.197B | 58.00 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.136B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.72 |
| MacroGenics (MGNX) | United States | $0.115B | 0.00 |
| Biote (BTMD) | United States | $0.102B | 4.46 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 24.00 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.77 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |